US Patent 7253187 Heterocyclic inhibitors of ERK2 and uses thereof
Patent 7253187 was granted and assigned to Vertex Pharmaceuticals on August, 2007 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7253187 Heterocyclic inhibitors of ERK2 and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
